Outbreaks and Incidents

Influenza vaccination saves lives
World Health Organization (WHO)
World Health Organization (WHO)
Influenza vaccination saves lives Influenza kills more than 650,000 people each year. Vaccination is our best tool to protect against severe influenza infections and deaths. As the virus evolves each year, WHO recommends annual influenza vaccination for health workers, older adults, people with chronic ...
Show Comments
Posted:
Measles: Nurse Julia brings vaccines to remote communities in Mexico for 30 years
World Health Organization (WHO)
World Health Organization (WHO)
Measles: Nurse Julia brings vaccines to remote communities in Mexico for 30 years Julia Paredes Lopez, a nurse with the Chihuahua Health Secretariat, has spent 30 years bringing vaccines to remote communities in Mexico. Her experience seeing children die of measles, a disease that is preventable through vaccination, inspired her to travel long ...
Show Comments
Posted:
Cervical cancer - HPV vaccination: Josephine’s vision for a cervical cancer free Malawi
World Health Organization (WHO)
World Health Organization (WHO)
Cervical cancer - HPV vaccination: Josephine’s vision for a cervical cancer free Malawi Josephine Kalombola, a mentor mother with Mothers2Mothers in Malawi, spends her days addressing young people’s concerns and misconceptions about human papillomavirus (HPV) in the country. Since Malawi has one of the highest cervical cancer mortality rates, Josephine encourages all girls ...
Show Comments
Posted:
Implementing the new UK Clinical Trials regulations
MHRAgovuk
MHRAgovuk
Implementing the new UK Clinical Trials regulations Implementing the new UK Clinical Trials regulations webinar, which took place on Tuesday 15 October 2024
Show Comments
Posted:
Antimicrobial resistance - World AMR Awareness Week 2024: educate, advocate and act now!
World Health Organization (WHO)
World Health Organization (WHO)
Antimicrobial resistance - World AMR Awareness Week 2024: educate, advocate and act now! WHO Director-General Dr Tedros Adhanom Ghebreyesus speaks about the urgent need to tackle antimicrobial resistance (AMR), which is undermining health care globally, and the importance of the World AMR Awareness Week (18 – 24 November).
AMR occurs when bacteria, ...
Show Comments
Posted:
What is the Yellow Card Biobank? (No subtitles)
MHRAgovuk
MHRAgovuk
What is the Yellow Card Biobank? (No subtitles) The Yellow Card Biobank is a collaboration between the Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England. Its goal is to improve understanding of how a patient’s genetic makeup may increase their risk of harm from side effects ...
Show Comments
Posted:
Emergencies and Outbreaks
Mpox (monkeypox) Mpox (monkeypox)
elombatd@who.int
Tue, 20/08/2024 - 09:08
Read more about Mpox (monkeypox)
Mpox (monkeypox) is an infectious disease caused by the monkeypox virus. It can cause a painful rash, enlarged lymph nodes ...
Posted:
COVID-19
COVID-19
Long COVID Basics Learn about the potential COVID-19 long-term effects, including fatigue, shortness of breath, brain fog, chest pain, headache, and other symptoms.
Posted:
COVID-19
COVID-19
Living with Long COVID People with post-COVID conditions and those who support them can find ways to help, ways to cope with stress, and additional resources and support groups.
Posted:
Emergencies and Outbreaks
Weekly bulletin Weekly bulletin
elombatd@who.int
Fri, 10/05/2024 - 19:18
Read more about Weekly bulletin
The Weekly Bulletin focuses on public health emergencies occurring in the WHO African Region. Each week, a brief description, followed ...
Posted:
COVID-19
COVID-19
COVID-19 Testing: What You Need to Know Learn about testing for COVID-19, including the types of tests, who should get tested, how to get tested, and print resources in English and Spanish.
Posted:
Emergencies and Outbreaks
Dengue Dengue
elombatd@who.int
Sat, 20/01/2024 - 18:12
Read more about Dengue
Dengue fever is an arbovirus transmitted by Aedes mosquitoes (both Ae. aegypti and Ae. albopiticus). It is a severe, flu-like illness that affects infants, young children and adults, ...
Posted:
Medicines and Healthcare products Regulatory Agency - Activity on GOV.UK
Press release: MHRA approves adapted Nuvaxovid JN.1 COVID-19 vaccine for adults and children aged 12... The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an adapted version of the Nuvaxovid COVID-19 vaccine that targets the Omicron JN.1 COVID-19 subvariant.

Load More